Zgibor Janice C, Maloney Maura A, Malmi Markku, Fabio Anthony, Kuo Shihchen, Solano Francis X, Tilves Debra, Tu Lichuan, Davidson Mayer B
Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, United States.
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, United States.
Contemp Clin Trials. 2018 Jan;64:201-209. doi: 10.1016/j.cct.2017.10.003. Epub 2017 Oct 6.
To evaluate changes in HbA1c, blood pressure, and LDLc levels in participants from practices where certified diabetes educators (CDEs) implemented standardized protocols to intensify treatment compared with those receiving usual care.
This clustered, randomized, clinical trial was implemented in community-based primary care practices. Fifteen primary care practices and 240 patients with type 2 diabetes were randomized to the intervention (n=175) or usual care (n=65). Participants had uncontrolled HbA1c, blood pressure, or LDLc. The one-year intervention included CDEs implementing pre-approved protocols to intensify treatment. Diabetes self-management education was also provided in both study groups.
The population was 50.8% male with a mean age of 61years. The HbA1c in the intervention group decreased from 8.8% to 7.8%, (p=0.001) while the HbA1c in the usual care group increased slightly from 8.2% to 8.3%. There was also a significant difference in HbA1c between the two groups (p=0.004). There was not a significant difference between groups for systolic blood pressure (SBP) or LDLc at the end of the intervention. Those in the intervention group were more likely to have glucose-lowering medications intensified and were more likely to have their HbA1c (35% vs 15%), SBP (80% vs 77%) and HbA1c, SBP, and LDLc at goal (11% vs 1.5%) compared with the usual care group. There was no significant difference in intensification of blood pressure or cholesterol medication.
Findings suggest that CDEs following standardized protocols in primary care is feasible and can effectively intensify treatment and improve glycemic control.
评估在执业机构中,与接受常规护理的参与者相比,接受认证糖尿病教育者(CDE)实施强化治疗标准化方案的参与者糖化血红蛋白(HbA1c)、血压和低密度脂蛋白胆固醇(LDLc)水平的变化。
这项整群随机临床试验在社区基层医疗执业机构中开展。15个基层医疗执业机构和240例2型糖尿病患者被随机分为干预组(n = 175)或常规护理组(n = 65)。参与者的HbA1c、血压或LDLc未得到控制。为期一年的干预措施包括CDE实施预先批准的强化治疗方案。两个研究组均提供糖尿病自我管理教育。
研究人群中男性占50.8%,平均年龄为61岁。干预组的HbA1c从8.8%降至7.8%(p = 0.001),而常规护理组的HbA1c从8.2%略有升至8.3%。两组之间的HbA1c也存在显著差异(p = 0.004)。干预结束时,两组的收缩压(SBP)或LDLc无显著差异。与常规护理组相比,干预组的降糖药物更有可能强化,且HbA1c(35%对15%)、SBP(80%对77%)以及HbA1c、SBP和LDLc达标的可能性更高(11%对1.5%)。血压或胆固醇药物的强化方面无显著差异。
研究结果表明,在基层医疗中,CDE遵循标准化方案是可行的,并且可以有效强化治疗并改善血糖控制。